The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vyvanse     Quarter: 2016Q3

Total Drug/Injury Combinations: 363     Number of Pages: 19

DRUGNAME PT EventCount
VYVANSE Sinus congestion 1 view events
VYVANSE Skin plaque 1 view events
VYVANSE Sleep apnoea syndrome 1 view events
VYVANSE Somatic delusion 1 view events
VYVANSE Somatic symptom disorder 1 view events
VYVANSE Somnambulism 1 view events
VYVANSE Suicidal behaviour 1 view events
VYVANSE Suspiciousness 1 view events
VYVANSE Swelling face 1 view events
VYVANSE Therapeutic response changed 1 view events
VYVANSE Thirst 1 view events
VYVANSE Thrombocytopenia 1 view events
VYVANSE Tooth resorption 1 view events
VYVANSE Trichotillomania 1 view events
VYVANSE Urinary incontinence 1 view events
VYVANSE Urinary retention 1 view events
VYVANSE Urine output increased 1 view events
VYVANSE Urticaria 1 view events
VYVANSE Vasospasm 1 view events
VYVANSE Viral upper respiratory tract infection 1 view events

Total Drug/Injury Combinations: 363     Number of Pages: 19

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)